We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$401M
Cap. Flow %
7.12%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149
Avg Time Held Equity + Options
3.9 quarters
Top 10 Avg Time Held Equity + Options
1.5 quarters
Top 20 Avg Time Held Equity + Options
1.3 quarters
Avg Time Held Equity only
4.1 quarters
Top 10 Avg Time Held Equity only
1.5 quarters
Top 20 Avg Time Held Equity only
1.3 quarters

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 39.86%
2 Healthcare 28.77%
3 Miscellaneous 7.24%
4 Real Estate 5.15%
5 Financials 4.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AURA icon
401
Aura Biosciences
AURA
$692M
$395K 0.01%
44,000
– –
2023 Q2
1 quarter
AFMD icon
402
DELISTED
Affimed
AFMD
$392K 0.01%
82,000
+47,910
+141% +$264K
2023 Q2
1 quarter
CTRE icon
403
CareTrust REIT
CTRE
$8.54B
$385K 0.01%
18,800
-6,470
-26% -$131K
2023 Q2
1 quarter
ESS icon
404
Essex Property Trust
ESS
$17.3B
$382K 0.01%
1,800
-34,700
-95% -$8.14M
2023 Q2
1 quarter
MRSN icon
405
DELISTED
Mersana Therapeutics
MRSN
$376K 0.01%
+11,857
New +$564K
2023 Q3
0 quarters
LKFT icon
406
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.95B
$376K 0.01%
10,888
-46,000
-81% -$1.79M
2023 Q1
2 quarters
EQIX icon
407
Equinix
EQIX
$101B
$363K 0.01%
+500
New +$387K
2023 Q3
0 quarters
VIR icon
408
Vir Biotechnology
VIR
$1.95B
$356K 0.01%
+38,000
New +$542K
2023 Q3
0 quarters
ROIC icon
409
DELISTED
Retail Opportunity Investments Corp.
ROIC
$342K 0.01%
27,600
-554,094
-95% -$7.64M
2021 Q2
9 quarters
JETS icon
410
PUT
US Global Jets ETF
JETS
$807M
$340K 0.01%
250,000
+100,000
+67% +$1.97M
2023 Q1
2 quarters
LYV icon
411
PUT
Live Nation Entertainment
LYV
$39.3B
$339K 0.01%
+37,500
New +$3.27M
2023 Q3
0 quarters
CTMX icon
412
CytomX Therapeutics
CTMX
$558M
$335K 0.01%
259,965
– –
2022 Q4
3 quarters
PEN icon
413
Penumbra
PEN
$12.6B
$331K 0.01%
1,369
– –
2022 Q1
6 quarters
EXPE icon
414
Expedia Group
EXPE
$32.5B
$309K 0.01%
3,000
-117,500
-98% -$13M
2022 Q2
5 quarters
AVTR icon
415
Avantor
AVTR
$10.5B
$305K 0.01%
14,470
-93,000
-87% -$1.98M
2022 Q1
6 quarters
CYPH icon
416
Cypherpunk Technologies Inc
CYPH
$341M
$303K 0.01%
219,434
+80,000
+57% +$186K
2023 Q1
2 quarters
ABOS icon
417
Acumen Pharmaceuticals
ABOS
$153M
$289K 0.01%
69,538
-10,000
-13% -$61.8K
2022 Q4
3 quarters
SMH icon
418
PUT
VanEck Semiconductor ETF
SMH
$72.3B
$287K 0.01%
+105,000
New +$15.9M
2023 Q3
0 quarters
ORIC icon
419
PUT
Oric Pharmaceuticals
ORIC
$1.25B
$285K 0.01%
+100,000
New +$819K
2023 Q3
0 quarters
RNG icon
420
RingCentral
RNG
$6.74B
$271K ﹤0.01%
9,155
-1,000
-10% -$33.2K
2023 Q1
2 quarters
VZIO icon
421
DELISTED
VIZIO Holding Corp.
VZIO
$271K ﹤0.01%
50,000
-150,000
-75% -$963K
2023 Q2
1 quarter
INTC icon
422
Intel
INTC
$539B
$267K ﹤0.01%
+7,500
New +$261K
2023 Q3
0 quarters
H icon
423
PUT
Hyatt Hotels
H
$15.1B
$260K ﹤0.01%
102,000
-135,000
-57% -$15.4M
2022 Q1
6 quarters
APLS icon
424
CALL
DELISTED
Apellis Pharmaceuticals
APLS
$248K ﹤0.01%
50,000
+25,000
+100% +$1.1M
2023 Q2
1 quarter
PRQR icon
425
ProQR Therapeutics
PRQR
$224M
$246K ﹤0.01%
189,328
– –
2023 Q1
2 quarters
15 16
17
18 19

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $401M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 16% a quarter earlier, followed by Healthcare and Miscellaneous.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.